Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2011

Nov 1, 2011

30339_dirs_2011-11-01_b5fc5887-9a2e-43ab-bd1d-e9d4a3a6a712.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-10-28

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-10-28 Common Stock A 32.6200 $40.8000 Acquired 24278.1774 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 377250.3728 Direct
Common Stock 1247.6666 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.